These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25032097)

  • 21. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes.
    Barritt AS; Dellon ES; Kozlowski T; Gerber DA; Hayashi PH
    J Clin Gastroenterol; 2011 Apr; 45(4):372-8. PubMed ID: 20733515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation.
    Maiwall R; Gupta M
    Transl Gastroenterol Hepatol; 2020; 5():18. PubMed ID: 32258522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
    Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.
    Gitto S; de Maria N; di Benedetto F; Tarantino G; Serra V; Maroni L; Cescon M; Pinna AD; Schepis F; Andreone P; Villa E
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):766-773. PubMed ID: 29505475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
    Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H
    Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic steatohepatitis and liver transplantation.
    Gitto S; Vukotic R; Vitale G; Pirillo M; Villa E; Andreone P
    Dig Liver Dis; 2016 Jun; 48(6):587-91. PubMed ID: 27038703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.
    Steggerda JA; Mahendraraj K; Todo T; Noureddin M
    World J Gastroenterol; 2020 Jul; 26(28):4018-4035. PubMed ID: 32821068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.
    Gadiparthi C; Spatz M; Greenberg S; Iqbal U; Kanna S; Satapathy SK; Broder A; Ahmed A
    J Clin Transl Hepatol; 2020 Jun; 8(2):215-221. PubMed ID: 32832402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis.
    Spiritos Z; Abdelmalek MF
    Transl Gastroenterol Hepatol; 2021; 6():13. PubMed ID: 33409407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
    Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
    Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
    Majumdar A; Tsochatzis EA
    Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?
    Canbay A; Sowa JP; Syn WK; Treckmann J
    Visc Med; 2016 Aug; 32(4):234-238. PubMed ID: 27722159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians.
    Choudhary NS; Dhampalwar S; Saraf N; Rastogi A; Bhangui P; Soin AS
    J Clin Exp Hepatol; 2024; 14(2):101281. PubMed ID: 38076440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.